Bradley Foster & Sargent Inc. CT trimmed its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 1.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 231,451 shares of the company’s stock after selling 3,987 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Procter & Gamble were worth $38,171,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $29,000. Transcendent Capital Group LLC acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $31,000. Ruedi Wealth Management Inc. increased its holdings in shares of Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the period. POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $34,000. Finally, Vima LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $35,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities analysts have issued reports on the stock. Dbs Bank cut shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective on the stock in a research note on Thursday, August 29th. Royal Bank of Canada boosted their price objective on shares of Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a research note on Wednesday, July 31st. Stifel Nicolaus boosted their price objective on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Finally, Citigroup boosted their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Seven investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $175.79.
Insider Activity
In other news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the sale, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at approximately $44,508,763.93. The disclosure for this sale can be found here. Insiders sold a total of 375,553 shares of company stock valued at $63,829,141 in the last 90 days. 0.17% of the stock is currently owned by insiders.
Procter & Gamble Price Performance
NYSE:PG opened at $175.93 on Wednesday. The firm has a market cap of $415.22 billion, a price-to-earnings ratio of 28.75, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The company’s 50-day moving average is $169.80 and its two-hundred day moving average is $165.49. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $177.94.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. During the same period in the prior year, the firm earned $1.37 EPS. The firm’s quarterly revenue was down .1% on a year-over-year basis. Research analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date was Friday, July 19th. Procter & Gamble’s dividend payout ratio is currently 65.85%.
Procter & Gamble Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Read More
- Five stocks we like better than Procter & Gamble
- How to Buy Cheap Stocks Step by Step
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Transportation Stocks Investing
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Investing In Automotive Stocks
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.